Linklaters, Davis Polk & Wardwell and Kirkland & Ellis have all won roles advising on Reckitt Benckiser’s (RB’s) $17.9bn acquisition of Mead Johnson.
RB, the UK-based maker of Nurofen painkillers and Durex condoms will takeover Mead Johnson, which makes infant formula under the Enfa brand and had sales of $3.7bn in 2016.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact [email protected]
